The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Value Of The Retinal Disorder Treatment Market Change Between 2026 And 2030?
The retinal disorder treatment market size has exhibited strong growth in recent years. It is forecast to rise from $13.69 billion in 2025 to $14.86 billion in 2026, at a compound annual growth rate (CAGR) of 8.6%. This historical expansion can be attributed to the increasing prevalence of age-related macular degeneration, the growing diabetic population worldwide, the proliferation of ophthalmology clinics and specialty hospitals, advancements in retinal imaging technologies, and improved awareness of retinal diseases.
The retinal disorder treatment market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $21.27 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.4%. This projected growth throughout the forecast period can be attributed to several factors, including the advancement of long-acting retinal medications, a rise in the approval of new biologics and gene therapies, enhanced availability of eye care in developing economies, increased funding for ophthalmic research, and a growing need for customized retinal therapies. Key developments expected during this period involve the wider acceptance of anti-VEGF treatments, a move towards less invasive retinal operations, a greater inclination for sustained-release drug delivery systems, the broadening of combination therapy strategies, and an increased utilization of at-home vision monitoring devices.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12701&type=smp
What Important Drivers Are Powering The Retinal Disorder Treatment Market Growth?
The future growth of the retinal disorder treatment market is projected to be propelled by the rising prevalence of diabetes. Diabetes is a long-term medical condition marked by elevated levels of blood glucose, resulting from the body’s inability to produce adequate insulin or effectively utilize the insulin it produces. Diabetic retinopathy stands as the most common retinal disorder among individuals with diabetes, caused by damage to the blood vessels in the retina, which can lead to bleeding, fluid leakage, and the proliferation of new blood vessels. Treatment for retinal disorders employs lasers to seal leaking blood vessels or eliminate abnormal ones. For instance, in June 2024, data from the National Health Service, a UK-based government department, revealed that in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes. This brought the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP, to 3,615,330, marking a significant increase compared to 3,065,825 in 2022. Consequently, the increasing prevalence of diabetes is driving the growth of the retinal disorder treatment market.
How Is Segment Classification Applied In The Retinal Disorder Treatment Market?
The retinal disorder treatment market covered in this report is segmented –
1) By Type: Macular Degeneration, Diabetic Retinopathy, Other Types
2) By Dosage Form: Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
Subsegments:
1) By Macular Degeneration: Dry Macular Degeneration, Wet Macular Degeneration
2) By Diabetic Retinopathy: Non-Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy
3) By Other Types: Retinal Detachment, Retinitis Pigmentosa, Uveitis, Other Retinal Disorders
What Trends Are Impacting The Retinal Disorder Treatment Market?
Leading companies in the retinal disorder treatment market are developing innovative offerings, such as treatments for geographic atrophy, to broaden their customer reach, boost sales, and generate higher revenue. Current therapeutic approaches for geographic atrophy primarily aim to manage symptoms, decelerate disease progression, and assist individuals in coping with visual impairment. For instance, in August 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, announced that IZERVAY had received U.S. Food and Drug Administration (FDA) approval. As a novel complement C5 inhibitor, IZERVAY distinguishes itself as the sole approved treatment for geographic atrophy (GA) that has demonstrated a statistically significant reduction (p<0.01) in the rate of GA progression at the 12-month primary endpoint across two Phase 3 clinical trials. This unique attribute firmly establishes IZERVAY (avacincaptad pegol intravitreal solution) as an indicated and effective therapy for GA secondary to age-related macular degeneration (AMD).
Which Firms Are Competing In The Retinal Disorder Treatment Market?
Major companies operating in the retinal disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Regeneron Pharmaceuticals Inc., Genentech Inc., Santen Pharmaceutical Co. Ltd., Apellis Pharmaceuticals Inc., Alimera Sciences Inc., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Adverum Biotechnologies Inc., Kodiak Sciences Inc., Acucela Inc., IVERIC bio Inc., Oxurion NV, Graybug Vision Inc., Clearside Biomedical Inc., Ophthotech Corporation, Opthea Limited, PanOptica Inc., ThromboGenics NV
Access The Complete Retinal Disorder Treatment Market Report:
https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report
Which Region Accounts For The Highest Share Of The Retinal Disorder Treatment Market?
North America was the largest region in the retinal disorder treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the retinal disorder treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Retinal Disorder Treatment Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=12701&type=smp
Browse Through More Reports Similar to the Global Retinal Disorder Treatment Market 2026, By The Business Research Company
Retinal Disorder Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report
Optic Nerve Disorders Treatment Market Report 2026
Retinal Biologics Market Report 2026
https://www.thebusinessresearchcompany.com/report/retinal-biologics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model